HIV vaccine (MVA BN)
comment: We have worked to strengthen vaccine developments with an improved humanized mouse model. We focus on recombinant vaccines against HIV driven by a powerful poxvirus vaccine system termed MVA BN. To improve our understanding MVA BN has been analyzed thoroughly on the nucleotide level, safety in cell cultures, immune deficient mice as well as in healthy, HIV–infected and other immune deficient humans.
type: Biomaterial
type: vaccine
has knowledgeable: Mark Suter
has organism type: Viruses